Vosoritide

ATC M05BX07 · 5 markets · 16 records

Vosoritide 5 markets · 16 records Forms

AU 7 records · 4 strengths

1.2 mginjectionVOXZOGO 1.2mg+1VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe unknown
0.56 mginjectionVOXZOGO 1.2mg+1VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe unknown
0.4 mginjectionVOXZOGO 1.2mg+1VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe unknown

Records without a stated strength · 1 VOXZOGO 1.2mg

CA 3 records · 3 strengths

1.2 mgpowderVOXZOGO 1.2mg
0.56 mgpowderVOXZOGO 1.2mg
0.4 mgpowderVOXZOGO 1.2mg

HK 3 records · 1 strengths

Records without a stated strength · 1 VOXZOGO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 0.4MG

TW 2 records · 2 strengths

2 mginjectionVoxzogo powder and solvent for solution for injection 2 mg/ml+1扶佐高凍晶注射劑2毫克/毫升
0.8 mginjectionVoxzogo powder and solvent for solution for injection 2 mg/ml+1扶佐高凍晶注射劑0.8毫克/毫升

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 VOXZOGO 1.2mg

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.